Upcoming shows
Real News

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



Maga First News

Upcoming Shows

Join The MAGA Network on Discord

0 0

U.S. transport chief defends FAA decision to not immediately ground Boeing 737 MAX

FILE PHOTO: U.S. Secretary Elaine Chao speaks to the news media outside of the West Wing of the White House
FILE PHOTO: U.S. Department of Transportation Secretary Elaine Chao speaks to the news media outside of the West Wing of the White House in Washington, U.S., March 4, 2019. REUTERS/Leah Millis/File Photo

April 10, 2019

(Reuters) – U.S. Transportation Secretary Elaine Chao defended the Federal Aviation Administration’s decision to not immediately ground the Boeing 737 MAX fleet after a second deadly crash in March of an airplane in Ethiopia.

Chao also said the FAA will “thoroughly review” Boeing’s final software upgrade package and training revisions once the airplane manufacturer submits it. “The department’s goal is to ensure public trust in aviation safety and preserve the preeminence of the United States as the gold standard in aviation safety,” Chao told a U.S. House panel.

(Reporting by David Shepardson; Editing by Chizu Nomiyama)

Source: OANN

0 0

Groom accused of sexual assault at wedding reception appears in court with wife: report

A lawyer for a New Jersey groom who allegedly groped an underage waitress at his own wedding reception last year has suggested a theory that proves his client is “an innocent man.”

Louis Busico, the attorney of 31-year-old Matthew Aimers, on Thursday claimed that the fact that his client’s wife was still with him proved the sexual assault allegations were false, the Philadelphia Inquirer reported.

GROOM SEXUALLY ASSUALTED WAITRESS AT WEDDING RECEPTION: COPS

“If he committed a crime, not even Dr. Phil could keep them together,” Busico said. “And the fact that they still are together shows that my client is an innocent man.”

The alleged incident took place in November 2018 at Aimers’ wedding reception at the Northampton Valley Country Club in Northampton Township, Pa. After a then-underage waitress spurned his alleged advances, she claimed he followed her into a bathroom, sexually assaulted her and exposed himself.

A judge on Thursday upheld all charges against Aimers, including indecent assault, indecent exposure, imprisonment of a minor, harassment and related counts, the Inquirer reported. The charges of simple assault, disorderly conduct, and resisting arrest stemming from a drunken brawl with police later that night were dropped, according to Philadelphia station WCAU-TV.

CLICK HERE TO GET THE FOX NEWS APP

Busico said his client “denies and rejects” the allegations made by the waitress, who has since turned 18, the Inquirer reported. Aimers' wife, Kayla, supports her husband “150 percent,” the lawyer said.

Fox News' Louis Casiano contributed to this report.

Source: Fox News National

0 0

Disturbing Increase in Colorectal Cancer in Young Adults

This article is dedicated to Breanne and Aston in hopes that efforts to identify what is driving this new epidemic of colorectal cancer in our children will lead not only to more effective treatments, but ultimately prevent this devastating disease.

I’m well aware of colorectal cancer in that the disease personally touched my mother in her 70s and my brother in his late 50s. But I was not aware of the alarming new trend of young adults in their 20s and 30s being diagnosed with this devastating disease. Recently, two of my friends in their early thirties have had their lives touched by colon cancer. Before this turn of events, they were incredibly healthy, athletic and taking on the world! Now, they are instead bravely facing surgery, chemotherapy and major lifestyle changes in an effort to regain their health.

A recent WebMD article acknowledged that one of the most significant and disturbing developments in colorectal cancer is the marked increase in younger individuals (which is decades before the American Cancer Society recommends people get screened for the disease). According to the article, by 2030, colorectal cancer incidence rates will be up 90% in people between ages 20 and 34, and 28% for people between ages 35 and 49. What is even more concerning is that often they are not diagnosed until later stages of the disease because most doctors are not thinking “cancer” when a young adult complains of abdominal pain or rectal bleeding.

Researchers describe this upward trend, which began in the late 1980s, as “ominous” and “worrisome.” Although the conventional wisdom is that risk for colorectal cancer (also referred to as colon, bowel or rectal cancer) increases with age, the rate at which adults over age 50 are being diagnosed has been declining. A 2017 study showed that those born around 1990 (i.e., currently in their late twenties) “have double the risk of colon cancer…and quadruple the risk of rectal cancer” compared with adults born around 1950. Similar patterns are playing out in other countries, with worldwide colon cancer deaths expected to increase by 60% by 2035, “especially among younger people.”

Why would Gen Xers and millennials increasingly be presenting with colorectal malignancies once deemed rare in the young? Most observers seem to be “grasping at straws” when it comes to furnishing an explanation. Some want to pin the blame on obesity as a “prime suspect”—but obesity cannot explain why colorectal cancers are repeatedly cropping up in healthy young athletes in “peak physical shape.” A leading oncologist whose colorectal cancer patients are mostly under age 40 recently confessed, “It’s hard to blame it on obesity alone. We suspect there is also something else going on.” The oncologist did not venture to guess what the “something else” might be.

According to the American Cancer Society, it takes anywhere from 10 to 15 years for an abnormal cell in the lining of the colon to develop into cancer. This means that the first abnormal cell growth that resulted in cancer occurred during childhood. Therefore, it is essential that we look at potential culprits and exposures occurring in childhood.

There are two possible contributors that temporally coincide not only with the spike in young adult colorectal cancers but also with the horrifying increase in childhood cancers. The first is the vaccine schedule’s inclusion of more viral vaccines since the late 1980s, and the known fact that viral vaccines are prone to various forms of contamination. Second, over the same time period, young people’s exposure to glyphosate has exploded, wreaking havoc with their gut bacteria—and intestinal imbalances have a well-documented association with colorectal cancer. In this article, I discuss the vaccine contamination issue; in Part II, I will consider glyphosate and the colorectal cancer crisis.


Alex exposes the globalist agenda that uses government agencies to cover up crimes against the population.

Learning From History

Viral vaccines have been plagued with problems of contamination since their earliest days, and, as Children’s Health Defense has discussed previously, these problems furnish a plausible link between vaccines and cancer. In fact, an independent website devoted to this topic describes the vaccine-cancer connection as “the biggest medical scandal in history,” making the crucial point that vaccine scientists’ use of contaminated cell lines from “the very birth of virology” has been “perpetuating and causing cancer” for decades. The Institute of Medicine tacitly acknowledged this in 2002 when it cited biological evidence supporting the theory that contamination of polio vaccines with simian virus 40 (SV40)—vaccines that were administered to millions of Americans in the late 1950s and early 1960s—“could contribute to human cancers.”

In the mid-1950s, Jonas Salk used the world’s most famous laboratory cells—HeLa cells—to develop his initial polio vaccine. Scientists had just succeeded in creating the cells—the first “immortal” (meaning endlessly cloned) human cell line—by feeding a cancer victim’s (Henrietta Lacks’) highly malignant cervical cancer cells with a nutrient mix containing blood and tissue from human placenta, beef embryo and live chicken heart. To the researchers’ delight, the HeLa cells responded to this treatment by multiplying “indefinitely” instead of aging.

However, researchers and government regulators soon backed off from the use of HeLa cells in vaccine production, deeming their malignant characteristics of rapid and immortal cell growth “not acceptable…for vaccine development” due to the “theoretical risk of transmitting cancer.” To produce viral vaccines, they instead relied on living animal cells that they erroneously perceived as safer, including the monkey cell line used in later iterations of Salk’s vaccine and other living cell types such as chicken embryos.

In Salk’s day, scientists may not have realized that their laboratory hodge-podge of animal and human blood and tissue was secretly facilitating the incorporation of “known and unknown viruses and bacteria” into their cell lines, nor that the HeLa cells themselves were capable of aggressively contaminating other cell lines—but a whistleblower named Walter Nelson-Rees later showed that this was in fact the case. Nelson-Rees proved in the 1970s that, very early on, Salk’s monkey cell line had been “invaded and taken over” by HeLa cells, and Salk unknowingly injected the contaminants into some of his human subjects. More recently, scientist Judy Mikovits has catalogued the risks of using animal tissues and cells to grow human viruses for viral vaccine production, stating that “re-injecting that material back into humans could introduce new animal viruses into the human population.”

Circling Back to Tumor Cells

For many years, Nelson-Rees and others persisted in trying to draw attention to the cell culture contamination problem, to little avail. In fact, rather than heed these conscientious researchers’ cautions, the Food and Drug Administration’s (FDA’s) vaccine regulators, in 2012, characterized the “current repertoire” of animal-derived cell lines as “inadequate” and proposed a startlingly risky about-face. Ignoring the past problems with HeLa cells and other forms of cell culture contamination, the FDA suggested that “cell lines derived from tumors may be the optimal and in some cases the only cell substrate that can be used to propagate certain vaccine viruses.

Matching deeds to words, the FDA also wasted no time in approving, that same year, the first cell-based influenza vaccine, hawking it to the public by praising its apparently superior performance compared to traditional egg-based flu vaccines. The Flucelvax vaccine is made from an immortal cell line “derived from a dog kidney and known to be tumorigenic in mice.” On its website, the FDA discreetly admits that “latent” cancer-causing viruses could potentially be present in these tumor-based cell lines and could pose a threat, “since they might become active under vaccine manufacturing conditions.” The agency also notes that latent viruses are “hard to detect using standard methods.”

The rapid approval of immortalized cell line vaccines stands in stark contrast to an internal document that I wrote about last year in which a leading FDA official contended, in 1999, that modern advances in vaccine technology were rapidly outpacing the ability to predict potential vaccine-related adverse events. The official argued for closer attention to safety issues from the earliest stages of vaccine development. “One of the important things is that the technology used to make these vaccines actually exceeds the science and technology to understand how these vaccines work and to predict how they will work,” stated Dr. Peter Patriarca, MD, Director of the Viral Products Division of the FDA Center for Biologics Evaluation and Research (CBER). While scientists use continuous cell lines for their ability to be propagated and grow viruses to a higher titer, Patriarca acknowledged that “the worst thing we are concerned about is malignancy, because some of these continuous cells even have the potential for growing tumors in laboratory animals.”

(Photo by Rubén Díaz / Flickr)

Something Old, Something New?

In an article describing pathogenic vaccine contamination, one author points to evidence that immortal cell lines “react differently” to various animal species, even when the species are “closely related,” and asks whether vaccine contaminants may likewise affect groups of people (such as the elderly versus infants) differently. This is an interesting question, given that one of the notable features of the colorectal cancers appearing in twenty- and thirty-somethings is that the malignancies often exhibit more biological aggressiveness than the colorectal cancers observed in older adults. One study reported that a unique type of cancer cell called “signet cell histology”—cells that “migrate more freely and exhibit a more aggressive mode of spread”—was nearly five times more prevalent in rectal cancer patients under age 40 than in older patients.

Other researchers have used high-throughput DNA sequencing techniques to make similar observations. Those methods reveal “different rates of genetic alterations” between adolescent and young adult colorectal cancer patients compared to older adults, “indicating potential molecular differences in the disease state and suggesting the need for alternative treatment strategies in younger patients.” Certainly, the American Cancer Society’s colorectal cancer screening recommendations, revised downward from age 50 to age 45 in 2018, will do little to help identify these aggressive cancers in younger adults.

Under the U.S. vaccine schedule, children receive numerous and recurrent doses of viral vaccines cultured in either human, monkey, bovine or chicken cells or in a multispecies combination of these cell types. These include viral vaccines against chickenpox, hepatitis, polio, rotavirus and measles-mumps-rubella. Compared to adults, young people have far greater exposure to these viral vaccines—and their inevitable contaminants. Could this have something to do with the age-related molecular differences being observed in colorectal cancers? No one really knows, because while the pharmaceutical industry is busily trying to develop cancer vaccines, it does not make a practice of assessing existing vaccines’ cancer risks. The all-too-typical disclaimer contained in most vaccine package inserts states that the vaccine “has not been evaluated for carcinogenic or mutagenic potential.”

The unacceptably high numbers of young adults who, in the prime of life, are being sidelined by debilitating colorectal cancers is a red flag telling us that we need to do better. We must find answers for what is causing this new epidemic of cancer in our children and what can be done to prevent it from occurring.

The viewpoints expressed here do not necessarily represent those of Infowars.


Alex Jones coins a new word while breaking down how elites manipulate online comments to control content creators.

Source: InfoWars

0 0

2020 candidate Andrew Yang defends $1,000 a month program, slams Dems for wanting to abolish Electoral College

Democratic presidential candidate Andrew Yang appeared on “Fox and Friends” Friday morning to defend his campaign’s key proposal of giving $12,000 to each American adult every year and criticized Democrats for their newfound support for the abolition of the Electoral College.

Yang, former ambassador of global entrepreneurship in the Obama administration and a long-shot candidate for the party’s nomination, was grilled by the show hosts and the audience about his universal basic income program, dubbed “Freedom Dividend,” and his other views.

“You have to look up who are going to be the biggest winners from artificial intelligence and self-driving cars and trucks and new technologies. Amazon, Google, Facebook and Uber. The American people are gonna see very little of the gains in the innovation,” said Yang.

"The American people are gonna see very little of the gains in the innovation."

— Andrew Yang

He added that due to an increasing automation, “most of us” won’t work at Amazon or other companies, leaving the rest of the people at a disadvantage because their source of income will disappear.

DEM 2020 CANDIDATE ANDREW YANG STANDS BY 'FREEDOM DIVIDEND'

Yang points out that his idea isn’t new in American politics as Alaska has had a petroleum dividend for about 40 years and remains to be widely popular among the people.

“Petroleum dividend works put aside the oil money whatever profits come out from the pipeline it goes to the Alaskan people. Everyone in Alaska is getting between $1 and $2,000 a year no questions asked.

“We need to do the same thing with technology and the new innovations in our economy. We can create a lot of the wealth. But the question is right now who is going to see that wealth? It's not going to be most Americans. It's going to be people who happen to be shareholders in these companies,” he added.

“We need to do the same thing with technology and the new innovations in our economy. We can create a lot of the wealth. But the question is right now who is going to see that wealth? It's not going to be most Americans. It's going to be people who happen to be shareholders in these companies.”

— Andrew Yang

Yang was also asked by the audience on issues other than his bold proposal, particularly whether he believes the Electoral College ought to be abolished, a view shared by leading 2020 presidential candidate Elizabeth Warren.

ELIZABETH WARREN SAYS SHE WANTS TO ELIMINATE THE ELECTORAL COLLEGE

“Getting rid of the Electoral College to me, I don't even know why we are talking about it in the sense that it has been part of our laws for decades and it would require a constitutional amendment to change Electoral College,” Yang said in response to a question from the audience.

“Do we really just want candidates just campaigning in major media markets and cities? The constitutional framers were very wise. I will say as a Democrat, it's very, very bad form to look like you’re trying to change the rules when you’ve been losing by the rules that everyone agreed on for decades.”

"I will say as a Democrat, it's very, very bad form to look like you’re trying to change the rules when you’ve been losing by the rules that everyone agreed on for decades.”

— Andrew Yang

He also reiterated during the show that his “Freedom Dividend” proposal isn’t a free lunch given to people while making it harder to become an American success story. Instead, he says, it’s a response to a changing economy that will negatively impact communities across the country.

GET THE FOX NEWS APP

“We have to face facts about the fact our economy is evolving in ways that are pushing more and more Americans to the sidelines and telling those Americans pushed to the sidelines like hey, you can be a multimillionaire success story, too, while Amazon is making 30% of the stores in their town closed doesn’t seem to be honest,” he said.

Source: Fox News Politics

0 0

Chris Wallace: Barr’s decision to make a conclusion on obstruction is ‘troubling’ and ‘politically charged’

“Fox News Sunday” anchor Chris Wallace said Friday Attorney General William Barr’s decision to make a conclusion on the question of obstruction of justice “seems even more troubling, and perhaps even more politically charged when you read the report.”

Wallace made the comment on “America’s Newsroom” Friday referencing Barr and Deputy Attorney General Rod Rosenstein ‘s determination there was not sufficient evidence on the obstruction front even though Special Counsel Robert Mueller did not reach a conclusion on whether President Trump committed this offense.

“When you read the report it becomes clear that the reason that Robert Mueller didn't make a finding on obstruction wasn't because he didn't feel capable of doing it, but because he thought in direct contradiction to what Bill Barr said yesterday, that under department guidelines, there could not be an indictment of a sitting president, and he very much left it to Congress to make that decision,” said Wallace Friday.

HOUSE JUDICIARY COMMITTEE ISSUES SUBPOENA FOR 'COMPLETE AND UNREDACTED' MUELLER REPORT

“So the fact that Barr decided to interpose himself and to make this decision himself, although Congress obviously can go ahead and do what it wants, really seems to go against the grain of what Robert Mueller was suggesting in his own report.”

Wallace referenced Barr’s statements to the press before the redacted Mueller report on the Russia investigation was released to the public on Thursday.

Barr offered a staunch defense of President Trump on Thursday morning during the press conference where he previewed the report’s findings and explained why he and Rosenstein concluded that the president had not obstructed justice.

Wallace also reacted to House Judiciary Committee Chairman Jerry Nadler’s push for Mueller’s “complete and unredacted” Russia report.

MUELLER REPORT IGNITES NEW DEM BATTLE OVER IMPEACHMENT

Nadler, D-N.Y., issued a subpoena Friday to obtain the "complete and unredacted" version of Mueller's report, as well as the underlying materials.

Wallace said the release of the unredacted report “has to be decided by a court.”

“The main thing they're talking about here is grand jury testimony. It is in fact the case that in the past, that attorneys general have gone to the courts and said -- gotten a court to agree, a judge to agree to release that information, to give it to Congress to fulfill its constitutional duties. Bill Barr chose not to do that. It now is on Jerry Nadler as the chairman of the House Judiciary Committee,” said Wallace.

“This will end up in the courts, and it’s going to end up, I suspect, taking months if not longer to determine whether or not they’re going to release that information. But given the kind of ill will that there seems to exist now between House Democrats and the attorney general, the idea that they would simply sit down and wait and accept whatever Barr decided he was going to redact and not redact, that ship seems to have sailed.”

CLICK HERE TO GET THE FOX NEWS APP

He added: “I think they are going to contest this and say we want to see everything that’s in there.”

Source: Fox News Politics

0 0

Kidnap suspect to face Sydney court for extradition to Chile

A woman wanted in Chile on kidnapping charges dating back to Chile's 1973-1990 military dictatorship is expected to appear in a Sydney court on Wednesday for an extradition hearing.

Chile's Supreme Court requested the extradition of Adriana Rivas in 2014. She was wanted for her alleged role in the 1976 killing of a Communist Party leader who was held in a secret prison before he was suffocated and thrown into the ocean.

Australian Attorney-General Christian Porter, who has responsibility for extraditions, said Rivas was arrested in Sydney on Tuesday at the request of Chile.

"This individual is wanted to face prosecution in the Republic of Chile for aggravated kidnapping offences," Chester said in a statement on Tuesday.

"As the matter is ongoing, it would not be appropriate to comment further," Chester added.

Information on an attorney was not immediately available on Wednesday.

Rivas was an assistant to Manuel Contreras, the head of the DINA secret police during Gen. Augusto Pinochet's dictatorship.

She moved to Australia in 1978 but was detained during a visit to Chile in 2006. Rivas was released after some months on probation and fled to Australia.

Rivas has been working as a part-time nanny and a cleaner in Sydney's wealthy eastern suburbs, Australian Broadcasting Corp. reported.

Chilean-born lawyer Adriana Navarro said the extradition process had been complex.

"There's been a number of technical obstacles along the way because the Chilean system of law is completely different to the Australian system," Navarro said. "That's why it's taken five years."

Navarro said the Chilean diaspora in Australia was ecstatic about Rivas' arrest.

"There's about 45,000 Chileans here and the majority of us, including myself, came to Australia fleeing the Pinochet dictatorship," Navarro said.

In 2014, Rivas told Australia's Special Broadcasting Service that she was innocent of the charges, but defended the use of torture in Chile at the time as necessary.

"They had to break the people — it has happened all over the world, not only in Chile," she said in Spanish.

Source: Fox News World

0 0

Brazil’s new status would not affect prior ag commitments: WTO chief

FILE PHOTO: 2019 World Economic Forum (WEF) annual meeting in Davos
FILE PHOTO: Roberto Azevedo, Director-General of the World Trade Organization (WTO) attends the World Economic Forum (WEF) annual meeting in Davos, Switzerland, January 24, 2019. REUTERS/Arnd Wiegmann

March 20, 2019

By Ana Mano

SAO PAULO (Reuters) – Brazil’s agreement with the United States to forgo special treatment by the World Trade Organization (WTO) would apply only to future negotiations within the multilateral trade body, Director General Roberto Azevedo said on Wednesday.

For example, Brazil’s self-defined status as a “developing” country has allowed it to subsidize up to 10 percent of its agricultural output, whereas the limit for “developed” nations is 5 percent, Azevedo said.

That would not change with Brazil’s potential new status, he said at a foreign trade seminar, because the plan to forgo the special WTO status would not affect prior agreements.

After a White House meeting on Tuesday, Brazilian President Jair Bolsonaro and U.S. President Donald Trump said in a joint statement that Brazil had agreed to begin a process to relinquish special and differential treatment in WTO negotiations, in line with a U.S. proposal. In return, the United States would back Brazil’s bid to become a member of the Organization for Economic Cooperation and Development (OECD), a forum for rich nations.

“The proposal would only concern future negotiations and whether countries would benefit or request differentiated treatment in WTO talks,” Azevedo said.

Azevedo said the United States has proposed new criteria to differentiate among a range of countries in the “developing” category, which includes major economies such as Brazil and China along with smaller nations such as Guatemala and Honduras.

According to Azevedo, such criteria could include whether a country is a member of the OECD or the G20 group of nations, and whether its participation in total global trade exceeds 0.5 percent.

(Reporting by Ana Mano; Editing by Richard Chang)

Source: OANN

NOW ON AIR
Now On Air

Story Time

1:00 am 6:00 am



Cambodian authorities have ordered a one-hour reduction in the length of school days because of concerns that students and teachers may fall ill from a prolonged heat wave.

Education Minister Hang Chuon Naron said in an announcement seen Friday that the shortened hours will remain in effect until the rainy season starts, which usually occurs in May. The current heat wave, in which temperatures are regularly reaching as high as 41 Celsius (106 Fahrenheit), is one of the longest in memory.

Most schools in Cambodia lack air conditioning, prompting concern that temperatures inside classrooms could rise to unhealthy levels.

School authorities were instructed to watch for symptoms of heat stroke and urge pupils to drink more water.

The new hours cut 30 minutes off the beginning of the school day and 30 minutes off the end.

School authorities instituted a similar measure in 2016.

Source: Fox News World

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Explosions have rocked Britain’s largest steel plant, injuring two people and shaking nearby homes.

South Wales Police say the incident at the Tata Steel plant in Port Talbot was reported at about 3:35 a.m. Friday (22:35 EDT Thursday). The explosions touched off small fires, which are under control. Two workers suffered minor injuries and all staff members have been accounted for.

Police say early indications are that the explosions were caused by a train used to carry molten metal into the plant. Tata Steel says its personnel are working with emergency services at the scene.

Local lawmaker Stephen Kinnock says the incident raises concerns about safety.

He tweeted: “It could have been a lot worse … @TataSteelEurope must conduct a full review, to improve safety.”

Source: Fox News World

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
The Wider Image: China's start-ups go small in age of 'shoebox' satellites
LinkSpace’s reusable rocket RLV-T5, also known as NewLine Baby, is carried to a vacant plot of land for a test launch in Longkou, Shandong province, China, April 19, 2019. REUTERS/Jason Lee

April 26, 2019

By Ryan Woo

LONGKOU, China (Reuters) – During initial tests of their 8.1-metre (27-foot) tall reusable rocket, Chinese engineers from LinkSpace, a start-up led by China’s youngest space entrepreneur, used a Kevlar tether to ensure its safe return. Just in case.

But when the Beijing-based company’s prototype, called NewLine Baby, successfully took off and landed last week for the second time in two months, no tether was needed.

The 1.5-tonne rocket hovered 40 meters above the ground before descending back to its concrete launch pad after 30 seconds, to the relief of 26-year-old chief executive Hu Zhenyu and his engineers – one of whom cartwheeled his way to the launch pad in delight.

LinkSpace, one of China’s 15-plus private rocket manufacturers, sees these short hops as the first steps towards a new business model: sending tiny, inexpensive satellites into orbit at affordable prices.

Demand for these so-called nanosatellites – which weigh less than 10 kilograms (22 pounds) and are in some cases as small as a shoebox – is expected to explode in the next few years. And China’s rocket entrepreneurs reckon there is no better place to develop inexpensive launch vehicles than their home country.

“For suborbital clients, their focus will be on scientific research and some commercial uses. After entering orbit, the near-term focus (of clients) will certainly be on satellites,” Hu said.

In the near term, China envisions massive constellations of commercial satellites that can offer services ranging from high-speed internet for aircraft to tracking coal shipments. Universities conducting experiments and companies looking to offer remote-sensing and communication services are among the potential domestic customers for nanosatellites.

A handful of U.S. small-rocket companies are also developing launchers ahead of the expected boom. One of the biggest, Rocket Lab, has already put 25 satellites in orbit.

No private company in China has done that yet. Since October, two – LandSpace and OneSpace – have tried but failed, illustrating the difficulties facing space start-ups everywhere.

The Chinese companies are approaching inexpensive launches in different ways. Some, like OneSpace, are designing cheap, disposable boosters. LinkSpace’s Hu aspires to build reusable rockets that return to Earth after delivering their payload, much like the Falcon 9 rockets of Elon Musk’s SpaceX.

“If you’re a small company and you can only build a very, very small rocket because that’s all you have money for, then your profit margins are going to be narrower,” said Macro Caceres, analyst at U.S. aerospace consultancy Teal Group.

“But if you can take that small rocket and make it reusable, and you can launch it once a week, four times a month, 50 times a year, then with more volume, your profit increases,” Caceres added.

Eventually LinkSpace hopes to charge no more than 30 million yuan ($4.48 million) per launch, Hu told Reuters.

That is a fraction of the $25 million to $30 million needed for a launch on a Northrop Grumman Innovation Systems Pegasus, a commonly used small rocket. The Pegasus is launched from a high-flying aircraft and is not reusable.

(Click https://reut.rs/2UVBjKs to see a picture package of China’s rocket start-ups. Click https://tmsnrt.rs/2GIy9Bc for an interactive look at the nascent industry.)

NEED FOR CASH

LinkSpace plans to conduct suborbital launch tests using a bigger recoverable rocket in the first half of 2020, reaching altitudes of at least 100 kilometers, then an orbital launch in 2021, Hu told Reuters.

The company is in its third round of fundraising and wants to raise up to 100 million yuan, Hu said. It had secured tens of millions of yuan in previous rounds.

After a surge in fresh funding in 2018, firms like LinkSpace are pushing out prototypes, planning more tests and even proposing operational launches this year.

Last year, equity investment in China’s space start-ups reached 3.57 billion yuan ($533 million), a report by Beijing-based investor FutureAerospace shows, with a burst of financing in late 2018.

That accounted for about 18 percent of global space start-up investments in 2018, a historic high, according to Reuters calculations based on a global estimate by Space Angels. The New York-based venture capital firm said global space start-up investments totaled $2.97 billion last year.

“Costs for rocket companies are relatively high, but as to how much funding they need, be it in the hundreds of millions, or tens of millions, or even just a few million yuan, depends on the company’s stage of development,” said Niu Min, founder of FutureAerospace.

FutureAerospace has invested tens of millions of yuan in LandSpace, based in Beijing.

Like space-launch startups elsewhere in the world, the immediate challenge for Chinese entrepreneurs is developing a safe and reliable rocket.

Proven talent to develop such hardware can be found in China’s state research institutes or the military; the government directly supports private firms by allowing them to launch from military-controlled facilities.

But it’s still a high-risk business, and one unsuccessful launch might kill a company.

“The biggest problem facing all commercial space companies, especially early-stage entrepreneurs, is failure” of an attempted flight, Liang Jianjun, chief executive of rocket company Space Trek, told Reuters. That can affect financing, research, manufacturing and the team’s morale, he added.

Space Trek is planning its first suborbital launch by the end of June and an orbital launch next year, said Liang, who founded the company in late 2017 with three other former military technical officers.

Despite LandSpace’s failed Zhuque-1 orbital launch in October, the Beijing-based firm secured 300 million yuan in additional funding for the development of its Zhuque-2 rocket a month later.

In December, the company started operating China’s first private rocket production facility in Zhejiang province, in anticipation of large-scale manufacturing of its Zhuque-2, which it expects to unveil next year.

STATE COMPETITION

China’s state defense contractors are also trying to get into the low-cost market.

In December, the China Aerospace Science and Industry Corp (CASIC) successfully launched a low-orbit communication satellite, the first of 156 that CASIC aims to deploy by 2022 to provide more stable broadband connectivity to rural China and eventually developing countries.

The satellite, Hongyun-1, was launched on a rocket supplied by the China Aerospace Science and Technology Corp (CASC), the nation’s main space contractor.

In early April, the China Academy of Launch Vehicle Technology (CALVT), a subsidiary of CASC, completed engine tests for its Dragon, China’s first rocket meant solely for commercial use, clearing the path for a maiden flight before July.

The Dragon, much bigger than the rockets being developed by private firms, is designed to carry multiple commercial satellites.

At least 35 private Chinese companies are working to produce more satellites.

Spacety, a satellite maker based in southern Hunan province, plans to put 20 satellites in orbit this year, including its first for a foreign client, chief executive Yang Feng told Reuters.

The company has only launched 12 on state-produced rockets since the company started operating in early 2016.

“When it comes to rocket launches, what we care about would be cost, reliability and time,” Yang said.

(Reporting by Ryan Woo; Additional reporting by Beijing newsroom; Editing by Gerry Doyle)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

At least one person is reported dead and homes have been destroyed by a powerful cyclone that struck northern Mozambique and continues to dump rain on the region, with the United Nations warning of “massive flooding.”

Cyclone Kenneth arrived just six weeks after Cyclone Idai tore into central Mozambique, killing more than 600 people and displacing scores of thousands. The U.N. says this is the first time in known history that the southern African nation has been hit by two cyclones in one season.

Forecasters say the new cyclone made landfall Thursday night in a part of Mozambique that has not seen such a storm in at least 60 years.

Mozambique’s local emergency operations center says a woman in the city of Pemba was killed by a falling tree.

Source: Fox News World

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
German drug and crop chemical maker Bayer holds annual general meeting
Werner Baumann, CEO of German pharmaceutical and chemical maker Bayer AG, attends the annual general shareholders meeting in Bonn, Germany, April 26, 2019. REUTERS/Wolfgang Rattay

April 26, 2019

By Patricia Weiss and Ludwig Burger

BONN (Reuters) – Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s $63 billion takeover of seed maker Monsanto.

Several large investors said they will not support aspirin investor Bayer’s management in a key vote scheduled for the end of its annual general meeting.

Bayer’s management, led by chief executive Werner Baumann, could see an embarrassing plunge in approval ratings, down from 97 percent at last year’s AGM, which was held shortly before the Monsanto takeover closed in June.

A vote to ratify the board’s actions features prominently at every German AGM. Although it has no bearing on management’s liability, it is seen as a key gauge of shareholder sentiment.

“Due to the continued negative development at Bayer, high legal risks and a massive share price slump, we refuse to ratify the management board and supervisory board’s actions during the business year,” Janne Werning, representing Germany’s Union Investment, a top-20 shareholder, said in prepared remarks.

About 30 billion euros ($34 billion) have been wiped off Bayer’s market value since August, when a U.S. jury found the pesticide and drugs group liable because Monsanto had not warned of alleged cancer risks linked to its weedkiller Roundup.

Bayer suffered a similar defeat last month and more than 13,000 plaintiffs are claiming damages.

Bayer is appealing or plans to appeal the verdicts.

Deutsche Bank’s asset managing arm DWS said shareholders should have been consulted before the takeover, which was agreed in 2016 and closed in June last year.

“You are pointing out that the lawsuits have not been lost yet. We and our customers, however, have already lost something – money and trust,” Nicolas Huber, head of corporate governance at DWS, said in prepared remarks for the AGM.

He said DWS would abstain from the shareholder vote of confidence in the executive and non-executive boards.

Two people familiar with the situation told Reuters this week that Bayer’s largest shareholder, BlackRock, plans to either abstain from or vote against ratifying the management board’s actions.

Asset management firm Deka, among Bayer’s largest German investors, has also said it would cast a no vote.

Baumann said Bayer’s true value was not reflected in the current share price.

“There’s no way to make this look good. The lawsuits and the first verdicts weigh heavily on our company and it’s a concern for many people,” he said, adding it was the right decision to buy Monsanto and that Bayer was vigorously defending itself.

This month, shareholder advisory firms Institutional Shareholder Services (ISS) and Glass Lewis recommended investors not to give the executive board their seal of approval.

(Reporting by Patricia Weiss and Ludwig Burger; Editing by Alexander Smith)

Source: OANN

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!

Listen to https://magaoneradio.net and Listen Daily! Don't Forget to Share Click a Link Below!
Current track

Title

Artist